Class ITerminatedD-0643-2022
Drug recall · February 23, 2022
PARAGARD T380A recall
Why: Non-sterility
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white rod in a Tyvek polyethylene pouch, Rx Only, Manufactured by Teva Women's Health Inc. a subsidiary of Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 51285-204-01
- Lots / codes
Lot # 517001,Exp 1/2024
- Quantity
- 48,645 cartons
- Company
- CooperSurgical, Inc, North Tonawanda, NY
- Distribution
- US Nationwide
- Initiated
- February 4, 2022 · Voluntary: Firm initiated
- Classified
- March 1, 2022
- Reported
- February 23, 2022
- Ended
- February 6, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.